PSITHERA

What this means for you

Approved and waiting on proof of use. It will register unless the applicant drops it, and its 09 Dec 2025 filing date already counts against anyone who files later.

Record

Serial number

99538015

Mark type

Stylized text

Filed

09 Dec 2025

Published for opposition

26 May 2026

Attorney of record

WADE SAVOY

Goods and services

• Class 005 — Pharmaceuticals: Pharmaceutical preparations for modulating proteins for medical purposes; Pharmaceutical preparations for the treatment of inflammatory diseases; Pharmaceutical preparations for the treatment of immunological diseases
• Class 042 — Scientific and technological services: Drug discovery services; Research and development in the pharmaceutical and biotechnology fields; Research and development in the field of biochemistry; Research and development in the field of molecular medicine; Research and development in the field of small-molecule pharmaceuticals; Research and development in the field of inflammatory and immunological diseases; Research and development in the field of allosteric inhibitors; Research and development in the field of drug discovery combining computation-based, physics-based, and biochemistry-based approaches

Owner

• Psivant Therapeutics, Inc., Watertown, MA, US
• Psivant Therapeutics, Inc., Watertown, MA, US

Prosecution history

• 09 Sept 2026 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
• 05 Aug 2026 — TEAS REQUEST TO DIVIDE RECEIVED
• 05 Aug 2026 — TEAS STATEMENT OF USE RECEIVED
• 05 Aug 2026 — SOU TEAS EXTENSION RECEIVED
• 21 Jul 2026 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
• 26 May 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
• 26 May 2026 — PUBLISHED FOR OPPOSITION
• 20 May 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
• 27 Apr 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
• 13 Apr 2026 — ASSIGNED TO EXAMINER
• 12 Feb 2026 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
• 09 Dec 2025 — APPLICATION FILING RECEIPT MAILED
• 09 Dec 2025 — NEW APPLICATION ENTERED